Improving Engagement With a Process Measure Dashboard Through Precision Feedback
1 other identifier
interventional
100
1 country
1
Brief Summary
The study seeks to assess the impact of e-mailing specific, targeted, practice-pattern based information ("precision feedback") on provider engagement with a dashboard for a quality process measure (showing stent omission after pre-stented ureteroscopy), compared with generic information ("one size fits most" feedback).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 20, 2024
CompletedStudy Start
First participant enrolled
July 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedJanuary 12, 2026
January 1, 2026
1.3 years
June 13, 2024
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clickthrough rate to the online dashboard
Clickthrough is defined as a link ever being clicked in the three months following e-mail send date, at which point in time a new e-mail will be sent. Clickthrough rate will be calculated as the number of clickthroughs divided by number of links sent (i.e., opportunities for clickthrough).
Every 3 months up to 15 months
Secondary Outcomes (6)
Total number of dashboard visits
15 months
Cumulative time (minutes) spent on the dashboard
15 months
Urologist opt-out rate
15 months
Helpful/not helpful rate
15 months
Stent rate for pre-stented ureteroscopy
15 months
- +1 more secondary outcomes
Study Arms (4)
Group 1 dashboard (3 months) then dashboard with Precision feedback (12 months)
EXPERIMENTALMonths 0-3 dashboard only, months 3-15 months dashboard with Precision feedback.
Group 2 dashboard (6 months) then dashboard with Precision feedback (6 months)
EXPERIMENTALMonths 0-6 dashboard only, months 6-15 months dashboard with Precision feedback.
Group 3 dashboard (9 months) then dashboard with Precision feedback (6 months)
EXPERIMENTALMonths 0-9 dashboard only, months 9-15 months dashboard with Precision feedback.
Group 4 dashboard (12 months) then dashboard with Precision feedback (3 months)
EXPERIMENTALMonths 0-12 dashboard only, months 12-15 months dashboard with Precision feedback.
Interventions
The Dashboard intervention, representing current standard of care, will consist of a standard e-mail message with a link to the dashboard and text explanation. No performance data will be included in the e-mail, and links will not be monitored for clickthrough with repeat e-mail.
The experimental intervention, precision feedback e-mail messaging, will consist of an e-mail with a link to the dashboard along with tailored information about a participant's performance in the quality process measure of interest. For example, e-mail subject lines may read "You have room for improvement in stent omission," accompanied by a visual display in the body of the e-mail showing a participant's performance relative to a top performing peer. The behavior change intervention delivery component will also involve modifications to existing procedures. Namely, performance feedback will be reported directly in the e-mail as either plain text, or an embedded or attached image with graphed data.
Eligibility Criteria
You may qualify if:
- Urologists participating in MUSIC that were in the top one hundred individuals in annual case volume from 2023 for "pre-stented ureteroscopy", the case for which the dashboard contents are most relevant.
You may not qualify if:
- \- Urologists that are not in the top one hundred individuals in annual "pre-stented ureteroscopy" case volume, urologists in the study team, or that opt out from the study at the individual or site level.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (2)
Lewicki P, Clark S, Shoemaker E, Wang B, Ross J, Daignault-Newton S, Carlozzi N, Martin-Schwarze A, Meurer W, Sales A, Ghani K, Dauw C, Stensland K. Rationale and protocol for a prospective clinical trial enrollment improvement hybrid study within a trial. Contemp Clin Trials Commun. 2025 Sep 20;48:101548. doi: 10.1016/j.conctc.2025.101548. eCollection 2025 Dec.
PMID: 41050879BACKGROUNDLewicki P, Salka B, Daignault-Newton S, Ross J, Krumm A, Ghani KR, Dauw C, Landis-Lewis Z, Stensland KD; Michigan Urological Surgery Improvement Collaborative. Rapid cycle, randomised testing of precision feedback to improve engagement with a process measure dashboard amongst urologists: study protocol for a hybrid trial. BMJ Open. 2025 May 6;15(5):e092742. doi: 10.1136/bmjopen-2024-092742.
PMID: 40335130DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristian Stensland, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Urology
Study Record Dates
First Submitted
June 13, 2024
First Posted
June 20, 2024
Study Start
July 17, 2024
Primary Completion
October 31, 2025
Study Completion
October 31, 2025
Last Updated
January 12, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share